Targeted interferons demonstrate potent apoptotic and anti-tumor activities
US-10182984-B2 · Jan 22, 2019 · US
This page is not indexed by search engines while we improve data quality.
Patent family 40468388
This patent family groups 4 related publications across US. Members often share priority claims or equivalent filings in different countries.
| Field | Value |
|---|---|
| Family ID | 40468388 |
| Family type | — |
| Earliest priority | Sep 21, 2007 |
| First filing country | US |
| Member publications | 4 |
| Countries | US |
| Representative publication | US10182984B2 — Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
Representative publication
Best representative member for this family based on priority and filing country.
US10182984B2 — Targeted interferons demonstrate potent apoptotic and anti-tumor activities (published Jan 22, 2019)
Member publications
Related publications in this family.
Targeted interferons demonstrate potent apoptotic and anti-tumor activities
US-2017151342-A1 · Jun 1, 2017 · US
Targeted interferons demonstrating potent apoptotic and anti-tumor activities
US-9534033-B2 · Jan 3, 2017 · US
Interferon-antibody fusion proteins demonstrating potent apoptotic and anti-tumor activities
US-9139634-B2 · Sep 22, 2015 · US